The psychiatry department conducts a wide variety of research that addresses a full range of brain diseases and psychiatric disorders. Learn more about our research centers and labs below.
The Institute brings together a broad, innovative network of collaborators dedicated to drug discovery, the development of novel therapeutics, lifestyle interventions and clinical applications to improve the outcomes of individuals with psychiatric illnesses.
The NIL is an interdepartmental, interdisciplinary group dedicated to ground-breaking work in animal models and human cognitive and clinical neuroscience using neuroimaging techniques across the lifespan.
Led by: Tamara Hershey, PhD
A multi-disciplinary team of clinician-scientists conducting research that addresses key public health priorities such as genomics research and substance use epidemiology and policy.
Led by Laura Bierut, MD and colleagues
Helping geriatric patients through a focus on mental and cognitive health through clinical trials of behavioral and medication treatments
Led by: Eric Lenze, MD
Multidisciplinary program dedicated to the study and rapid treatment of complex mood and anxiety disorders.
Conducts neuroimaging, clinical and epidemiologic research geared towards the early identification and management of psychotic and related illnesses, with the goal of reducing their burden on individuals and their families.
Led by: Daniel Mamah, MD, MPE
Studying the genetic and environmental pathways to disorders of social development in childhood, with the goal of devising and implementing the most effective interventions and treatments.
Led by: John Constantino, MD
Identification and treatment of early onset mental disorders, including depression.
Led by: Joan Luby, MD
Led by: Susan Perlman, PhD